Conclusions
Understanding of mitochondrial dysfunction in CFS will clearly benefit from more study. Our findings warrant detailed studies on larger patient and control populations. The siting of mitochondrial impairment may lead to approaches for alleviating some of the symptoms of CFS. Studies on the effects of cytokines on cellular and mitochondrial bioenergetics are important to see whether cytokines or similar molecules are involved in linking CFS immune disturbances to mitochondrial dysfunction, and to better understand the consequences of cytokine therapies for cancer and viral infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson, G. M., and Billings, R. E., 1992, Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes, Arch. Biochem. Biophys. 294:223–229.
Aoki, T., Miyakoshi, H., Usuda, Y., and Hernerman, R. B., 1993, Low NK syndrome and its relationship to chronic fatigue syndrome, Clin. Immunol. Immunopath. 69:253–265.
Barbiroli, B., Montagna, P., Martinelli, P., Lodi, R., Lotti, S., Cortelli, P., Funicello, R., and Zaniol, P., 1993, Defectivebrainenergymetabolism by in vivo3lpmr spectroscopy in 28 patients with mitochondrial cytopathies, J. Cereb. Blood Flow Metab. 13:469–474.
Barke, R. A., Brady, P. S., and Brady, L. J., 1991, The Ca2+ second messenger system and interleukin-I-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation, Surgery 110:285–294.
Behan, W. H. M., More, A.R., and Behan, P. O., 1991, Mitochondrial abnormalities in the postviral fatigue syndrome, Acta Neuropathol. 83:61–65.
Bengtsson, A, and Henriksson, K. G., 1989, The muscle in fibromyalgia: A review of Swedish studies, J. Rheumatol. 16:144–149.
Bock, G. R., and Whelan, J. (Eds.), 1993, Chronic Fatigue Syndrome, Ciba Foundation Symposium 173, Wiley, Chichester, England.
Buchwald, D., 1991, Laboratory abnormalities in chronic fatigue syndrome, in PostViral Fatigue Syndrome (R. Jenkins and J. Mobray, Eds.), Wiley, Sussex, England, pp. 117–136.
Buchwald, D., and Komaroff, A.L., 1991, Review of laboratory findings for patients withchronic fatigue syndrome, Rev. Infect. Dis. 13:S12–18.
Buchwald, D., Umali, P., Kith, P., Perlman, B. A., and Komaroff, A. L., 1995, Chronic fatigue and chronic fatigue syndrome: Prevalence in a Pacific Northwest health care system, Ann. Int. Med. 123:81–88.
Caligiuri, M., Murray, C., Buchwald, D., Levine, H., Cheney, P., Peterson D., Komaroff, A. L., and Ritz, J., 1987, Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome, J. Immunol. 139:3306–3313.
Cannon, J. G., Angel, J. B., Abad, L. W., Vannier, E., Mileno, M. D., Fagioli, L., Wolff, S. M., and Komaroff, A. L., 1997, Interleukin-1β interleukin-1 receptor antagonist, and soluble interleukin-lreceptor type II secretion in chronic fatigue syndrome, J. Clin. Immunol. 17:253–261.
Carofoli, E., and Roman, I., (1980), Mitochondria and disease, Mol Aspects Med. 3:297–400.
Chacon, E., Reece, J. M., Nieminen, A.-L., Zahrebelski, G., Herman, B., and Lemasters, J. J., 1994, Distribution of electrical potential, pH, free Ca2+, and volume inside cultured adult rabbit myocytes during chemical hypoxia: A multiparameter digitized confocal microscopic study, Biophys. J. 66:942–952.
Chazotte, B., and Pettengill, M., 1998, Cytokine effects on mitochondrial membrane potential and possible mitochondrial dysfunction in chronicfatigue and immune dysfunction syndrome, ASBMB J. May 1998.
Chazotte, B., and Pettengill, M., 1999, Using membrane potential to follow cytokinc effects on mitochondria and possible dysfunction in chronic fatigue syndrome, Biophys. J. 76:A363.
Chazotte, B., Loehr, J.P., and Hackenbrock, C.R., 1996, Quantitative analyses of membrane potential of mitochondria in individual living human cells related to chronic illness, FASEB J. 10:A1377.
Cheney, P., and Lapp, C. W., 1992, The diagnosis of chronic fatigue syndrome: An assertive approach, CFIDS Chronicle Physician’s Forum, Sept. 13–19.
Cho, W. K., and Stollerman, G. H., 1992, Chronic fatigue syndrome, Hospital Practice Sept 15 27:221–245.
Coates, P. M., Hale, D. E., Stanley, C. A., Corkey, B. E. and Cortner, J. A., 1985, Genetic deficiency of medium-chain Acyl-Co A dehyrogenase: Studies in cultured skin fibroblasts and peripheral mononuclear leukocytes, Pediat. Res. 19:671–676.
Dawson, D. M., and Sabin, T. D. (Eds.), Chronic Fatigue Syndrome, Little, Brown, Boston, 1993.
Demitrack, M. A., 1994, Neuroendocrine aspects of chronic fatigue syndrome: Implications for diagnosis and research, in Chronic Fatigue Syndrome (S. E. Straus, Ed.), Marcel Dekker, New York.
Demitrack, M. A., and Crofford, L. J., 1998, Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation infibromyalgia and chronic fatigue syndrome, Ann. NY Acad. Sci. 840:684–697.
DiMauro, S., Bonillia, E., Zeviani, M., Nakagawa, M., and DeVivo, D. C., 1985, Mitochondrial myopathies, Annu. Neurol. 17:521–538.
Frackowiak, R. S. J., Herold, S., Petty, R. K. H., and Morgan-Hughes, J. A., 1988, The cerebral metabolism of glucose and oxygenmeasured withpositron tomography in patients withmitochondrialdiseases, Brain 111:1009–1024.
Fukuda, K., and Gantz, N. M., 1995, Management strategies for chronic fatigue syndrome, Fed. Pract. July.
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., and Komaroff, A., 1994, The chronic fatigue syndrome: A comprehensive approach to its definition and study, Ann. Intern. Med. 121:953–959.
Geng, Y.-j., Hansson, G. K., and Holme, E., 1992, Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells, Circ. Rex. 71:1268–1276.
Grafman, J., Johnson, R., and Scheffers, M., 1991, Cognitive and mood-state changes in patients with chronic fatigue syndrome, Rev. Infect. Dis. 13:S45–S52.
Gunn, W. J., Connell, O. B., and Randell, B., 1993, Epidemiology of chronic fatigue syndrome: The Centers for Disease Control Study, in Chronic Fatigue Syndrome, (G. R. Bock and J. Whelan, Eds.), CIBA Foundation Symposium 173, Wiley, Chichester, England, pp. 83–108.
Ho-Yen, D. O., Carrington, D., and Armstrong, A. A., 1988, Myalgic encephalomyelitis and alpha-interferon, Lancet i:125–127.
Holms, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberger, L. B., Straus, S. E., Jomes, J. F., Dubois, R. E., Cunningham-Rundles, C., Pahwa, S., Tosato, G., Zegans, L. S., Purtilo, D. T., Brown, N., Schooley, R. T., and Brus, 1., 1998, Chronic fatigue syndrome: A working case definition, Ann. Intern. Med. 108: 387–389.
Hyde, B. M., and Jain, A., 1992, Clinical observations of CNS dysfunction in post-infectious, acute onset M.E./C.F.S., in The Clinical and Scientific Basis of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (B. M. Hyde, J. A. Goldstein, P. H. Levine, Eds.), the Nightingale Foundation, Ottawa, Canada, pp. 38–57.
Hyde, B. M., Goldstein, J. A., and Levine, P. H. (Eds.), The Clinical and Scientific Bash of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, The Nightingale Foundation, Ottawa, Canada.
Gunn, W. J., Connell, D. B., and Randell, B., 1993, Epidemiology Chronic Fatigue Syndrome: The Centers for Disease Control Study In Chronic Fatigue Syndrome, (G. R. Bock and J. Whelan, eds.), Ciba Foundation Symposium’ 93. Wiley, Chichester, England.
Jamal, G. A., and Hansen, S., 1985, Electrophysiological studies in the post-viral fatigue syndrome, J. Neurol, Neuorsurg. Psychiat. 48:691–694.
Jenkins, R., and Mowbray, J. (Eds), 1991, Post-Viral Fatigue Syndrome, Wiley, Chichester, England.
Jones, J. F., 1991, Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus, Rev. Inject. Dis. 13:S26–S31.
Kartounis, L. D., Troung, D. D., Morgan-Hughes, J. A., and Harding, A. E., 1992, The neuropsychological features of mitochondrial myopathies and encephalopathies, Arch. Neurol. 49:158–160.
Klimas, N. G., Salvato, F. R., Morgan, R., and Fletcher, M. A., 1990, Immunologic abnormalities in chronic fatigue syndrome, J. Clin. Microbiol. 28:1403–1410.
Komaroff, A. L., 1997, A 56-year-old woman with chronic fatigue syndrome, JAMA 278:1179–1185.
Komaroff, A. L., and Buchwald, D. S., 1998, Chronic fatigue syndrome: An update, Annu. Rev. Med. 49: 1–13.
Kruit, W. H., Punt, K. J., Goey, S. H., de Mulder, p. H., van Hoogenhuyze, D. C., Henzen-Logmans, W, and Stoter, G., 1994, Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon, Cancer 74:2850–2856.
Kuratsume, H., Yamaguti, K., Takahashi, M., Misaki, H., Tagawa, S., and Kitani, T., 1994, Acylcarnitine deficiency in chronic fatigue syndrome, Clin. Infect. Dis. 18:S62–S67.
Lane, R. J. M., Burgess, A. P., Flint, J., Riccio, M., and Archard, L. C., 1995, Exercise responses and psychiatric disorder chronic fatigue syndrome, Brit. Med. J. 311:544–545.
Lane, R. J. M., Barrett, M. C., Taylor, D. J., Kemp, G. J., and Lodi, R., 1998a, Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle, Neuromus. Disord. 8:204–209.
Lane, R. J. M., Barrett, M. C., Woodrow, D., Moss, J., Fletcher, R., and Archard, L. C., 1998b, Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome, J. Neurol. Neurosurg. Psychiat. 64:362–367.
Lemasters, J. J., Chacon, E., Zahrebelski, G., Reece, J. M., and Nieminen, A.-L., 1993a, Laser scanning confocal microscopy of living cells, in Optical Microscopy: Emerging Methods and Applications (B. Herman and J. J. Lemasters, Eds), Plenum, New York, pp 339–354.
Lemasters, J. J., Nieminen, A.-L., Chacon, E., Imberti, R., Gores, G. J., Reece, J. M., and Herman, B., 1993b, Use of fluorescent probes to monitor mitochondrial membrane potential in isolated mitochondria, cell suspensions, and cultured cells, in Mitochondrial Dysfunction Methods in Toxicology, Vol. 2 (L. H. Lash, and D. P. Jones, Eds.), Academic, New York, pp. 404–415.
Lever, A. M. L., Lewis, D. M., Bannister, B. A., Fry, M., and Berry, N., 1988, Interferon production in postviral fatigue syndrome, Lancet ii:l01.
Levy, J. A., 1994, Viral studies of chronic fatigue syndrome, Clin. Infect. Dis. 18:S117–S120.
Lloyd, A., Hickie, I., Brockman, A., Dwyer, J., and Wakefield, D., 1991, Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome, J. Infect. Dis. 164:1023–1024.
MacDonald, E., 1987, Interferons as mediators of psychiatric morbidity; An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers, Lancer ii: 1175–1178.
McCully, K. K.., Natelson, B. H., Lotti, S., Sisto, S., Leigh, J. S., 1996, Reduced oxidative metabolism in chronic fatigue syndrome, Muscle and Nerve 19:621–625.
McGregor, N. R., Dunstan, R. H., Zerbes, M, Butt, H. L., Roberts, T. K., and Klineberg, I. J., 1996, Preliminary determination of a molecular basis to chronic fatigue syndrome, Biochem. Mol. Med. 57:73–80.
Montague, T. J., Marrie, T. J., Klassen, G. A., Bewick, D. J., and Horacek, B. M,, 1989, Cardiac function at rest and with exercise in the chronic fatigue syndrome, Chest 95:779–784.
Nakagawa, K., Miller, F. N., Sims, D. E., Lentsch, A. B., Miyazaki, M., and Edwards, M. J., 1996, Mechanisms of interleukin-2 hepatic toxicity, Cancer Rex. 56:507–510.
Natelson, B. H., Cohen, J. M., Brassloff, I., and Lee, H. J., 1993, A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J. Neural. Sci. 120:203–207.
Ojo-Amaze, H. A., Conley, E. J., and Peter, J. B., 1994, Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome, Clin. Infect. Dis. 18:S157–S159.
Pawley J. B., Handbook of Biological Confocal Microscopy, 2nd ed., Plenum, New York, 1995.
Peterson, P. L., 1995, The treatment of mitochondrial myopathies and encephalomyopathies, Biochim. Biophys. Acta 1271:275–280.
Petit, P. X., O’Conner, J. E., Grunwald, D., and Brown, S. C., 1990, Analysis of the membrane potential of rat-and mouse-liver mitochondria by flow cytometry and possible applications, Eur. J Biochem. 193:389–397.
Plioplys, A. V, and Plioplys, S., 1997, Amantadine and L-carnitine treatment of chronic fatigue syndrome, Neuropsychobio. 35:16–23.
Rasmussen, H., Nielsen, H., Andersen, V, Barington, T., Bendtzen, K.., Hansen, S., Nielsen, L., Pedersen, B. K.., and Wiik, A., 1994, Chronic fatigue syndrome: A controlled cross-sectional study, J. Rheumatol. 21:1527–1531.
Reyes, M., Gary, H. E., Jr., Dobbins, J. G., Randall, B., Steele, L., Fukuda, K.., Holms, G. P., Connell, D. G., Mawle, A. C., Schmid, D. S., Stewart, J. A., Schonberger, L. B., Gunn, W. J., and Reeves, W. C., 1997, Surveillance for chronic fatigue syndrome: Four U. S. cities, September 1989 through August 1993, MMWR 46:1–13.
Roe, C.R., and Coates, P. M., 1989, Acyl-CoA dehydrogenase deficiencies, in Metabolic Bases of Inherited Disease, 6th ed. (C. R., Scribner, A. L. Beaudet, W. A. Sly, and D. Valle Eds.), McGraw-Hill, NY, pp. 889–914.
Rowe, P. C., Bou-Holaigah, I., Kan, J. S., and Calkins, H., 1995, Is neurally mediated hypotension an unrecognized cause of chronic fatigue? Lancet 345:623–624.
Sandman, C. A., Barron, J. L., Nackoul, K.., Goldstein, J., and Fidler, F., 1993, Memory deficits associated with chronic fatigue immune dysfunction syndrome, Biol. Psychiat, 33:618–623.
Schwartz, R. B., Garada, B. M., Komaroff, A. L., Tice, H. M., Gleit, M., Jolez, F. A., and Holman, B. L., 1993a, Detection of intracranial abnormalities in patients with chronic fatigue syndrome: Comparison of MR imaging and SPECT, Am. J. Rad. 162:935–941.
Schwartz, R. B., Komaroff, A. L., Garada, B. M., Gleit, M., Doolittle, T. H., Bates, D. W., Vasile, R. G., and Holman, B. L., 1993b, SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression, Am. J. Rad. 162:943–951.
Straus, S. E., 1988, The chronic mononucleosis syndrome, J. Infect. Dis. 157:405–412.
Straus, S. E. (Ed.), 1994, Chronic Fatigue Syndrome, Marcel Dekker, New York.
Vojdani, A., Ghoneum, M., Choppa, P. C., Magatoto, L., and Lapp, C. W., 1997, Elevatedapoptotic cell population in patients with chronic fatigue syndrome: The pivotal role of protein kinase RNA, J. Int. Med. 242:465–478.
Wallace, D. A., 1992, Mitochondrial DNA diseases, Ann. Rev. Biochem. 61:1175–1212.
Wong, R., Lopaschuk, G., Zhu, G., Walker, D., Catellier, D., Burton D., Teo, K. Collins-Nakai, R., and Montague, T, 1992. Skeletal muscle metabolism in the chronic fatigue syndrome. Chest 102:1716–1722.
Zar, J. H., 1985, Biostatistical Analysis, 2nd ed., Prentice-Hall, Englewood Cliffs, New Jersey
Zhang, C., Baumer, A., Mackay, I. R., Linnane, A. W., and Nagley, P., 1995, Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome, Hum. Mol. Genet. 4:751–754.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Chazotte, B. (2002). Mitochondrial Dysfunction in Chronic Fatigue Syndrome. In: Lemasters, J.J., Nieminen, AL. (eds) Mitochondria in Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46835-2_21
Download citation
DOI: https://doi.org/10.1007/0-306-46835-2_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46433-1
Online ISBN: 978-0-306-46835-3
eBook Packages: Springer Book Archive